BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 20180283)

  • 1. Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer.
    De Craene S; Surmont V; van Meerbeeck JP
    Curr Opin Oncol; 2010 Mar; 22(2):102-11. PubMed ID: 20180283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer.
    De Pauw R; van Meerbeeck JP
    Curr Opin Oncol; 2007 Mar; 19(2):92-7. PubMed ID: 17272979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
    Maas KW; El Sharouni SY; Smit EF; Schramel FM
    Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-small cell lung cancer: Perioperative treatments].
    Westeel V; Schipman B; Jacoulet P
    Presse Med; 2011 Apr; 40(4 Pt 1):398-403. PubMed ID: 21420825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy.
    Van Meerbeeck JP; De Pooter C; Raskin J; Janssens A; Van Schil PE
    Curr Opin Oncol; 2020 Jan; 32(1):54-62. PubMed ID: 31688138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative chemotherapy and chemoradiotherapy for non-small-cell bronchial cancers].
    Milleron B; Mornex F; Martin E; Epaud C; Massiani MA
    Cancer Radiother; 2002 Nov; 6 Suppl 1():105s-113s. PubMed ID: 12587388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended surgical resection in stage III non-small cell lung cancer.
    Hillinger S; Weder W
    Front Radiat Ther Oncol; 2010; 42():115-121. PubMed ID: 19955797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?].
    Pagès PB; Pforr A; Delpy JP; Abou Hanna H; Bernard A
    Rev Mal Respir; 2015 May; 32(5):485-92. PubMed ID: 25498767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
    Yamaguchi M; Fukuyama Y; Ichinose Y
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of multimodality therapy in locoregional non-small cell lung cancer.
    Martini N; Kris MG; Ginsberg RJ
    Surg Oncol Clin N Am; 1997 Oct; 6(4):769-91. PubMed ID: 9309093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.
    Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D
    Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of induction therapy for resectable non-small cell lung cancer.
    Stinchcombe TE; Socinski MA
    Drugs; 2007; 67(3):321-32. PubMed ID: 17335293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer.
    Deutsch M; Crawford J; Leopold K; Wolfe W; Foster W; Herndon J; Blackwell S; Yost R
    Cancer; 1994 Aug; 74(4):1243-52. PubMed ID: 8055445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?
    Wozniak AJ; Gadgeel SM
    Oncology (Williston Park); 2007 Feb; 21(2):163-71; discussion 171, 174, 179-82. PubMed ID: 17396481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant approach for nonsmall cell lung cancer: overview of the current issues.
    Francolini G; Ferrari K; Scotti V
    Curr Opin Oncol; 2017 Mar; 29(2):123-128. PubMed ID: 28027103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the evidence in favour of neoadjuvant chemotherapy in stage IIIA (N2) non-small cell lung cancer solid enough?
    Felip E; Rosell R
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):305-10. PubMed ID: 11057084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.